GEODE CAPITAL MANAGEMENT, LLC - HTG MOLECULAR DIAGNOSTICS IN ownership

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 22 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q3 2020$127,000
-54.2%
385,6450.0%0.00%
Q2 2020$277,000
+121.6%
385,6450.0%0.00%
Q1 2020$125,000
-76.9%
385,645
-50.0%
0.00%
Q4 2019$540,000
+227.3%
771,290
+216.6%
0.00%
Q3 2019$165,000
-59.2%
243,6330.0%0.00%
Q2 2019$404,000
-32.2%
243,633
+2.2%
0.00%
Q1 2019$596,000
-46.1%
238,453
-45.3%
0.00%
Q4 2018$1,106,000
+15.7%
435,930
+130.1%
0.00%
Q3 2018$956,000
+54.9%
189,4930.0%0.00%
Q2 2018$617,000
-6.5%
189,493
+3.9%
0.00%
Q1 2018$660,000
+1550.0%
182,401
+818.5%
0.00%
Q4 2017$40,000
+21.2%
19,8590.0%0.00%
Q3 2017$33,000
-36.5%
19,8590.0%0.00%
Q2 2017$52,000
-62.0%
19,8590.0%0.00%
Q1 2017$137,000
+211.4%
19,8590.0%0.00%
Q4 2016$44,000
-4.3%
19,8590.0%0.00%
Q3 2016$46,000
-9.8%
19,8590.0%0.00%
Q2 2016$51,000
-8.9%
19,8590.0%0.00%
Q1 2016$56,000
-34.9%
19,8590.0%0.00%
Q4 2015$86,000
-43.0%
19,8590.0%0.00%
Q3 2015$151,00019,8590.00%
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q3 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 535,590$2,705,0001.58%
Millrace Asset Group, Inc. 200,000$1,010,0000.79%
Private Wealth Partners, LLC 1,000,000$5,050,0000.77%
PERKINS CAPITAL MANAGEMENT INC 249,700$1,261,0000.76%
Timpani Capital Management LLC 206,119$1,041,0000.30%
Diametric Capital, LP 64,329$325,0000.28%
Granahan Investment Management 941,170$4,753,0000.26%
Kalos Management, Inc. 69,900$308,0000.16%
SYMMETRY PEAK MANAGEMENT LLC 85,000$429,0000.15%
B. Riley Wealth Advisors, Inc. 250,000$1,263,0000.15%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders